Half-year report · HY
4552.TEDINET S100X3NF
Period2025-04-01 → 2025-09-30
Filed2025-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Amended by S100YF1R (2026-06-23).
Key figures · 45
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥21.4bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥33.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥16.7bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥2.4bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | −¥739m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥2.4bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | −¥7.5bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.6bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥2.5bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥556m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.7bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥4.8bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥691m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.7bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | −¥680m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥109.1bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥104.9bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥104.6bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥60.5bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥57.4bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥48.5bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥47.4bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥57.0bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥15.6bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥13.2bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥15.6bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.2bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥18.3bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥18.8bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.3bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥5.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥706m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥9.9bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥770m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥9.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.9bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥14.03 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-38.43 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.53 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥14.03 | 2025-04-01 → 2025-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 44.1% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.8% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.1% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 471
| Item | Context | Value | Unit |
|---|---|---|---|
| Salaries and allowances sga | Prior1InterimDuration | 1226000000 | JPY |
| Salaries and allowances sga | InterimDuration | 1194000000 | JPY |
| Provision for bonuses sga | Prior1InterimDuration | 472000000 | JPY |
| Provision for bonuses sga | InterimDuration | 520000000 | JPY |
| Provision for directors bonuses sga | Prior1InterimDuration | 63000000 | JPY |
| Provision for directors bonuses sga | InterimDuration | 62000000 | JPY |
| Retirement benefit expenses sga | Prior1InterimDuration | 34000000 | JPY |
| Retirement benefit expenses sga | InterimDuration | 37000000 | JPY |
| Research and development expenses sga | Prior1InterimDuration | 6576000000 | JPY |
| Research and development expenses sga | InterimDuration | 7835000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2025-11-14 | |
| Semi annual accounting period cover page | FilingDateInstant | Original text (Japanese)第51期中（自 2025年４月１日 至 2025年９月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)ＪＣＲファーマ株式会社 | |
| Company name in english cover page | FilingDateInstant | JCR Pharmaceuticals Co.,Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役会長兼社長 芦田 信 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)兵庫県芦屋市春日町３番19号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)芦屋 0797(32)1995 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)上席執行役員経営戦略本部長 伊藤 洋 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)兵庫県芦屋市春日町３番19号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)芦屋 0797(32)1995 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)上席執行役員経営戦略本部長 伊藤 洋 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E00973 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 45520 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)ＪＣＲファーマ株式会社 | |
| Filer name in english | FilingDateInstant | JCR Pharmaceuticals Co.,Ltd. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2025-04-01 | |
| Current period end date | FilingDateInstant | 2025-09-30 | |
| Type of current period | FilingDateInstant | HY | |
| Current fiscal year end date | FilingDateInstant | 2026-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2024-04-01 | |
| Comparative period end date | FilingDateInstant | 2024-09-30 | |
| Previous fiscal year end date | FilingDateInstant | 2025-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |